What You Should Know:
– Remedy Meds, LLC, a consumer virtual-care and pharmacy platform, today announced it has entered into a definitive agreement to acquire Thirty Madison, Inc. (“Thirty Madison”).
– The transaction creates a larger, multi-brand platform across women’s, men’s, and metabolic health. The transaction, which is valued just north of $500M, will be funded through an all-stock deal.
Expanding Access Through a Unified Multi-Brand Ecosystem
Thirty Madison, a leading provider of virtual specialty care, is set to join forces with Remedy Meds to build one of the largest consumer-centric telehealth platforms. Together, the combined entity will deliver accessible, affordable, and high-quality care across multiple categories, serving patients with conditions ranging from men’s hair loss and women’s health needs to migraine and weight management. The closing is anticipated in Q4 2025, pending customary regulatory approvals.
The new platform will unite Remedy Meds (weight loss), Keeps (men’s hair loss), Nurx (women’s health), and Cove (migraine), enhancing patient trust and improving funnel efficiency across categories. With nationwide clinician coverage, integrated insurance support, and a robust pharmacy fulfillment network, patients will benefit from same-day video consultations, rapid prescription review, personalized treatment plans, and seamless medication delivery.
Driving Scale, Integration, and Strong Financial Growth
The strategic combination delivers:
- Scaled multi-brand presence – A comprehensive platform that deepens consumer trust while creating cross-category growth opportunities.
- Integrated care and pharmacy infrastructure – Full-service telemedicine enhanced by insurance coverage and direct-to-door pharmacy delivery.
- Robust financial performance – Remedy Meds’ $450M+ annual revenue and strong profitability will amplify Thirty Madison’s already profitable $220M+ business, creating a sustainable scaled operating model.
“By bringing together Thirty Madison’s trusted brands with Remedy Med’s acquisition engine, retention system, and pharmacy infrastructure, we will broaden access, shorten time-to-treatment, and maintain the financial discipline that has defined our growth,” said Haris Memon, Founder and CEO of Remedy Meds.
